Literature DB >> 1652352

Occurrence of an active form of gelatinase in human gastric and colorectal carcinoma tissues.

S Yamagata1, Y Yoshii, J G Suh, R Tanaka, S Shimizu.   

Abstract

Profiles of gelatinase released during 4 h incubation of explants from human carcinoma tissues (15 gastric and 15 colorectal carcinomas) in serum-free RPMI 1640 medium were compared with those of corresponding normal tissue specimens obtained 2 and 10 cm apart from tumor periphery. All the culture supernatants of both tumor and normal tissues contained gelatinase species of 200, 130, 92 and 72 kDa as detected by zymography with gelatin as a substrate. Besides these gelatinase species, all carcinoma tissue culture supernatants had an additional 66-kDa gelatinase, an active form of the 72-kDa gelatinase. This gelatinase was not detectable in the normal tissues 10 cm apart from the tumor mass, with an exceptional case of gastric carcinoma of Borrmann type 4. These results suggest that the presence of active form of gelatinase might be one of the characteristic properties of these malignant human tumors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652352     DOI: 10.1016/0304-3835(91)90135-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  A new prognostic strategy for gastric carcinoma: mRNA expression of tumor growth-related factors in endoscopic biopsy specimens.

Authors:  M Nakamura; M Katano; K Fujimoto; T Morisaki
Journal:  Ann Surg       Date:  1997-07       Impact factor: 12.969

2.  MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells.

Authors:  H Pulyaeva; J Bueno; M Polette; P Birembaut; H Sato; M Seiki; E W Thompson
Journal:  Clin Exp Metastasis       Date:  1997-03       Impact factor: 5.150

3.  Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in metastatic MDCK cells transformed by v-src.

Authors:  H Noritake; H Miyamori; C Goto; M Seiki; H Sato
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

4.  Expression and activity of matrix metalloproteinases-2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients.

Authors:  Christian G Sauer; Alexandra Kappeler; Monika Späth; Jens J Kaden; Maurice S Michel; Doris Mayer; Uwe Bleyl; Rainer Grobholz
Journal:  Virchows Arch       Date:  2004-04-16       Impact factor: 4.064

5.  Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts.

Authors:  R V Ward; S J Atkinson; J J Reynolds; G Murphy
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

6.  Active MMP-2 effectively identifies the presence of colorectal cancer.

Authors:  Mary Jo Murnane; Jinguo Cai; Sania Shuja; David McAneny; Veronica Klepeis; John B Willett
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

7.  Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.

Authors:  C F Sier; F J Kubben; S Ganesh; M M Heerding; G Griffioen; R Hanemaaijer; J H van Krieken; C B Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

8.  Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer.

Authors:  A Kumar; H M Collins; J H Scholefield; S A Watson
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

9.  Diuretic response to cyclophosphamide in rats bearing a matrix metalloproteinase-9-producing tumour.

Authors:  Y Mizushima; K Sassa; T Hamazaki; T Fujishita; R Oosaki; M Kobayashi
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

10.  Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy.

Authors:  S L Parsons; S A Watson; H M Collins; N R Griffin; P A Clarke; R J Steele
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.